328 related articles for article (PubMed ID: 18721856)
1. The HSA affinity of warfarin and flurbiprofen determined by fluorescence anisotropy measurements of camptothecin.
Wybranowski T; Cyrankiewicz M; Ziomkowska B; Kruszewski S
Biosystems; 2008 Dec; 94(3):258-62. PubMed ID: 18721856
[TBL] [Abstract][Full Text] [Related]
2. INTERACTION OF CAMPTOTHECIN WITH HUMAN SERUM ALBUMIN DETERMINED BY FLUORESCENCE ANISOTROPY SPECTROSCOPY.
Wybranowski T; Ziomkowska B; Cyrankiewicz M; Kruszewski S
Acta Pol Pharm; 2016; 73(1):29-34. PubMed ID: 27008798
[TBL] [Abstract][Full Text] [Related]
3. High-resolution and high-throughput protocols for measuring drug/human serum albumin interactions using BIACORE.
Rich RL; Day YS; Morton TA; Myszka DG
Anal Biochem; 2001 Sep; 296(2):197-207. PubMed ID: 11554715
[TBL] [Abstract][Full Text] [Related]
4. The fluorescent probe prodan characterizes the warfarin binding site on human serum albumin.
Moreno F; Cortijo M; González-Jiménez J
Photochem Photobiol; 1999 Jan; 69(1):8-15. PubMed ID: 10063798
[TBL] [Abstract][Full Text] [Related]
5. The comparison of biophysical properties of DB-67 and its ester DB-67-4ABTFA determined by fluorescence spectroscopy methods.
Kruszewski S; Ziomkowska B; Cyrankiewicz M; Wybranowski T
Biosystems; 2008 Dec; 94(3):270-5. PubMed ID: 18718502
[TBL] [Abstract][Full Text] [Related]
6. Electrospray ionization mass spectrometry as a tool for determination of drug binding sites to human serum albumin by noncovalent interaction.
Benkestock K; Edlund PO; Roeraade J
Rapid Commun Mass Spectrom; 2005; 19(12):1637-43. PubMed ID: 15915474
[TBL] [Abstract][Full Text] [Related]
7. Binding of urapidil to human serum albumin: dependency on free fatty acid concentration.
Storck J; Kirsten R
Int J Clin Pharmacol Ther Toxicol; 1991 May; 29(5):204-8. PubMed ID: 2071271
[TBL] [Abstract][Full Text] [Related]
8. Competition between serum albumin and soluble fraction of liver for binding of warfarin and other drugs.
Wosilait WD; Ryan MP; Byington KH
Res Commun Chem Pathol Pharmacol; 1981 Apr; 32(1):113-21. PubMed ID: 7291718
[TBL] [Abstract][Full Text] [Related]
9. Paclitaxel-HSA interaction. Binding sites on HSA molecule.
Trynda-Lemiesz L
Bioorg Med Chem; 2004 Jun; 12(12):3269-75. PubMed ID: 15158795
[TBL] [Abstract][Full Text] [Related]
10. Binding characteristics of KNI-272 to plasma proteins, a new potent tripeptide HIV protease inhibitor.
Kiriyama A; Nishiura T; Ishino M; Yamamoto Y; Ogita I; Kiso Y; Takada K
Biopharm Drug Dispos; 1996 Dec; 17(9):739-51. PubMed ID: 8968527
[TBL] [Abstract][Full Text] [Related]
11. Location of high and low affinity fatty acid binding sites on human serum albumin revealed by NMR drug-competition analysis.
Simard JR; Zunszain PA; Hamilton JA; Curry S
J Mol Biol; 2006 Aug; 361(2):336-51. PubMed ID: 16844140
[TBL] [Abstract][Full Text] [Related]
12. Influences of haemodialysis on the binding sites of human serum albumin: possibility of an efficacious administration plan using binding inhibition.
Nishio T; Takamura N; Nishii R; Tokunaga J; Yoshimoto M; Kawai K
Nephrol Dial Transplant; 2008 Jul; 23(7):2304-10. PubMed ID: 18390890
[TBL] [Abstract][Full Text] [Related]
13. Characterization of an important drug binding area on human serum albumin including the high-affinity binding sites of warfarin and azapropazone.
Fehske KJ; Schläfer U; Wollert U; Müller WE
Mol Pharmacol; 1982 Mar; 21(2):387-93. PubMed ID: 6808349
[TBL] [Abstract][Full Text] [Related]
14. Interaction of acrylodan with human serum albumin. A fluorescence spectroscopic study.
Moreno F; Cortijo M; González-Jiménez J
Photochem Photobiol; 1999 Nov; 70(5):695-700. PubMed ID: 10568165
[TBL] [Abstract][Full Text] [Related]
15. Site I on human albumin: differences in the binding of (R)- and (S)-warfarin.
Bertucci C; Canepa A; Ascoli GA; Guimaraes LF; Felix G
Chirality; 1999; 11(9):675-9. PubMed ID: 10506426
[TBL] [Abstract][Full Text] [Related]
16. Human serum albumin binding assay based on displacement of a non selective fluorescent inhibitor.
Thorarensen A; Sarver RW; Tian F; Ho A; Romero DL; Marotti KR
Bioorg Med Chem Lett; 2007 Aug; 17(16):4646-9. PubMed ID: 17560104
[TBL] [Abstract][Full Text] [Related]
17. In vivo antitumor activity of camptothecin incorporated in liposomes formulated with an artificial lipid and human serum albumin.
Watanabe M; Kawano K; Toma K; Hattori Y; Maitani Y
J Control Release; 2008 May; 127(3):231-8. PubMed ID: 18384903
[TBL] [Abstract][Full Text] [Related]
18. Characterization of drug-protein binding process by employing equilibrium sampling through hollow-fiber supported liquid membrane and Bjerrum and Scatchard plots.
Barri T; Trtić-Petrović T; Karlsson M; Jönsson JA
J Pharm Biomed Anal; 2008 Sep; 48(1):49-56. PubMed ID: 18565712
[TBL] [Abstract][Full Text] [Related]
19. Determining molecular binding sites on human serum albumin by displacement of oleic acid.
Sarver RW; Gao H; Tian F
Anal Biochem; 2005 Dec; 347(2):297-302. PubMed ID: 16289007
[TBL] [Abstract][Full Text] [Related]
20. Novel 7-(dimethylamino)fluorene-based fluorescent probes and their binding to human serum albumin.
Park KK; Park JW; Hamilton AD
Org Biomol Chem; 2009 Oct; 7(20):4225-32. PubMed ID: 19795061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
